At a glance
ClinicalIndex Comparison RecordN/ACompleted· 601 enrolled
Drug / intervention
CBTprobehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of an Artificial Intelligence- Informed Digital Tool to Help Clinicians Practice Cognitive Behavioral Therapy for Psychosis (CBTp)
In Brief
A clinical study evaluating CBTpro for Psychosis and 4 related conditions. Completed, enrolled 601 participants across 13 sites.
Detailed Summary
The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsychosis, Schizophrenia, Schizo Affective Disorder, Bipolar Disorder, Depressive Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH), Lyssn.io, Inc.
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartJun 2022
Primary CompletionDec 2024
TodayJul 2026
First PostedNov 19, 2021
Enrollment StartJun 28, 2022
Primary CompletionDec 9, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.6 years ago
Interventions
CBTprobehavioral
CBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.